POTETI, MARTINA
POTETI, MARTINA
Scienze Biomediche, Sperimentali e Cliniche 'Mario Serio'
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential
2021 Poteti M.; Menegazzi G.; Peppicelli S.; Tusa I.; Cheloni G.; Silvano A.; Mancini C.; Biagioni A.; Tubita A.; Mazure N.M.; Lulli M.; Rovida E.; Dello Sbarba P
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features
2020 Tusa I.; Cheloni G.; Poteti M.; Silvano A.; Tubita A.; Lombardi Z.; Gozzini A.; Caporale R.; Scappini B.; Dello Sbarba P.; Rovida E.
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors
2018 Tusa, I; Cheloni, G; Poteti, M; Gozzini, A; Deng, X; Gray, N S; Li, S; Dello Sbarba, P; Rovida, E
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells
2018 Ignazia Tusa,Giulia Cheloni, Martina Poteti, Antonella Gozzini, Ngoc Ho DeSouza, Yi Shan, Xianming Deng, Nathanael S. Gray, Shaoguang Li, Elisabetta Rovida, Persio Dello Sbarba
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction
2017 Cheloni, G; Poteti, M; Bono, S; Masala, E; Mazure, N; Rovida, E; Lulli, M; Dello Sbarba, P
uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines
2020 Alessio Biagioni, Anna Laurenzana, Anastasia Chillà, Mario Del Rosso, Elena Andreucci, Martina Poteti, Daniele Bani, Daniele Guasti, Gabriella Fibbi, Francesca Margheri
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential | 2021 | Poteti M.; Menegazzi G.; Peppicelli S.; Tusa I.; Cheloni G.; Silvano A.; Mancini C.; Biagioni A.; Tubita A.; Mazure N.M.; Lulli M.; Rovida E.; Dello Sbarba P | |
| In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features | 2020 | Tusa I.; Cheloni G.; Poteti M.; Silvano A.; Tubita A.; Lombardi Z.; Gozzini A.; Caporale R.; Scappini B.; Dello Sbarba P.; Rovida E. | |
| Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors | 2018 | Tusa, I; Cheloni, G; Poteti, M; Gozzini, A; Deng, X; Gray, N S; Li, S; Dello Sbarba, P; Rovida, E | |
| Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells | 2018 | Ignazia Tusa,Giulia Cheloni, Martina Poteti, Antonella Gozzini, Ngoc Ho DeSouza, Yi Shan, Xianming Deng, Nathanael S. Gray, Shaoguang Li, Elisabetta Rovida, Persio Dello Sbarba | |
| The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction | 2017 | Cheloni, G; Poteti, M; Bono, S; Masala, E; Mazure, N; Rovida, E; Lulli, M; Dello Sbarba, P | |
| uPAR knockout results in a deep glycolytic and OXPHOS reprogramming in melanoma and colon carcinoma cell lines | 2020 | Alessio Biagioni, Anna Laurenzana, Anastasia Chillà, Mario Del Rosso, Elena Andreucci, Martina Poteti, Daniele Bani, Daniele Guasti, Gabriella Fibbi, Francesca Margheri |